utilities

Tag Archives | Drug trials

Latest Blogrss link

Global partnerships to meet the dementia challenge

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

Eleven more years. That is the G8 summit declaration; a cure or disease-modifying treatment for dementia by 2025. Fortunately, our scientists are not short on the drive or inspiration needed to step-up to this challenge and push forward with their pioneering research. Here, at Alzheimer’s Research UK, we fund biomedical research to find a cure. […]

In the news: B vitamins and Alzheimer’s disease

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

A new analysis of several clinical trials has drawn a conclusion that will dismay many: taking B vitamins does not slow the decline in memory and thinking skills that comes with age. The results suggest that B vitamins are unlikely to prevent Alzheimer’s disease. The news is the opposite of what we, and the hundreds of thousands of […]

The failure rate of clinical trials for Alzheimer’s – why we need to raise our game

Dr Simon Ridley

This is a cross blog post with Alzheimer’s Research & Therapy. Dementia is the name for a collection of many different conditions, of which Alzheimer’s disease is the most common. Alzheimer’s is characterised by a gradual decline in memory and changes in behaviour and communication. In the later stages, people often forget their friends and family […]

Read more

What’s the point of a blood test for Alzheimer’s?

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

This time last week brought news of a potential blood test for Alzheimer’s, capable of detecting the disease before symptoms appear. Nearly every national newspaper carried headlines about the research, and our spokespeople were called on to help explain the implications of the study – and its limitations – for several broadcast stations. Efforts to […]

What to expect from the next five years of dementia research

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

Yesterday, our Director of Research Dr Eric Karran spoke about his hopes for the development of new Alzheimer’s treatments, saying that he is ‘more encouraged for the future now, than he has ever been’. This rallying call comes only a few days before the G8 dementia summit takes place in London. The G8 event will […]

What difference can you make to dementia research?

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

This is a cross Blog post with The Dementia Challenge. As the UK’s leading dementia research charity, people often ask us whether they can help with the research effort in dementia. The answer is yes and there are lots of different ways to get involved. Everyone has their own reasons for getting involved in research. […]

Placebo Tea

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

In this short piece I’m going to describe why we need clinical trials to develop new Alzheimer’s treatments. And cups of tea. What is the placebo effect? It’s been shown over and over again that patients who are given empty injections or pills, which they believe contain medicine, experience symptom improvement. This happens in a […]

When is a failed clinical trial not a failure?

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

Back in 2002, the news broke that Elan had halted its phase II clinical trial for the AN1792 vaccine, designed to combat Alzheimer’s. It was a severe disappointment for people with Alzheimer’s and their loved ones. Many hopes had been pinned on the vaccine, and its failure saw those hopes dashed for hundreds of thousands […]

Right drug, right patient, right time

Dr Laura PhippsKirsty MaraisRobin BrisbourneKaty StubbsEd PinchesFiona Calverthonor pollardClaire Bromley

This month we’ll be at the political party conferences urging all parties to continue to back dementia research. With no new drugs since 2003, and those in existence only showing modest efficacy, we desperately need new treatments that can delay the onset, slow the progression and manage the symptoms of dementia. Only through research can we make progress and offer hope to people with dementia.